Association of the -1082 G/A promoter polymorphism of interleukin-10 gene with the autoantibodies production in patients with rheumatoid arthritis

Clinical Rheumatology

Volumn 28, Issue 8, 2009, Pages 899-905

  Nemec, Petr ^a   Pavkova Goldbergova, Monika ^a   Gatterova, Jindra ^b   Fojtik, Zdenek ^a   Vasku, Anna ^a   Soucek, Miroslav ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Autoantibody; Gene; Interleukin 10; Polymorphism; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 10; RHEUMATOID FACTOR;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RHEUMATOID FACTOR; YOUNG ADULT;

EID: 67849119568     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1168-1     Document Type: Article

References (38)

1. Reveille JD (1998) The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 10(3):187-200
2. Winchester R (1994) The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 56:389-466
3. Singal DP, Li J, Lei K (1999) Genetics of rheumatoid arthritis (RA): Two separate regions in the major histocompatibility complex contribute to susceptibility to RA. Immunol Lett 69(3):301-306
4. Rowley MJ, Stockman A, Brand CA, Tait BD, Rowley GL, Sherritt MA, Mackay IR, Muirden KD, Bernard CC (1997) The effect of HLA-DRB1 disease susceptibility markers on the expression of RA. Scand J Rheumatol 26(6):448-455
5. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM (1994) Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 24(11):2699-2705
6. Hart PH, Ahern MJ, Smith MD, Finlayjones JJ (1995) Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol 99(3):331-337
7. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Urayama S, Kawabe Y, Aoyagi T, Maeda K, Nagataki S (1997) Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis. Imunology 91(2):252-259
8. Brennan FM (1999) IL-10 and arthritis. Rheumatology 38(4):293-297
9. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349(9046):170-173
10. Pretolani M, Goldman M (1997) IL-10. A potential therapy for allergic inflammation? Immunol Today 18(6):277-280
11. Perez L, Orte J, Brieva JA (1995) Terminal differentiation of spontaneous rheumatoid factor-secreting B-cells from rheumatoid arthritis patients depends on endogenous interleukin-10. Arthritis Rheum 38(12):1771-1776
12. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, Fujita K, Lipsky PE (1995) Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 38(1):96-104
13. Eskdale J, Kube D, Tesch H, Gallagher G (1997) Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 46(2):120-128
14. Eskdale J, Gallagher G (1995) A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 42(5):444-445
15. Eskdale J, Kube D, Gallagher G (1996) A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics 45(1):82-83
16. Field M, Gallagher G, Eskdale J, McGarry F, Richards SD, Munro R, Oh HH, Campbell C (1997) Tumor necrosis factor locus polymorphisms in rheumatoid arthritis. Tissue Antigens 50(3):303-307
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classiffication of rheumatoid arthritis. Arthritis Rheum 31(3):315-324
18. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, Decker JL, Genant HK, Gofton JP, Goodman N et al (1985) How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis. Arthritis Rheum 28(12):1326-1335
19. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG, Kiessling R (1994) Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180(6):2371-2376
20. Rennick DM, Fort MM, Davidson NJ (1997) Studies with IL-10(-/-') mice: an overview. J Leukoc Biol 61(4):389-396
21. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM (1995) IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96(5):2304-2310
22. Persson S, Mikulowska A, Narula S, Ogarra A, Holmdahl R (1996) Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 44(6):607-614
23. Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M, van den Berg WB (1997) Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 40(2):249-260
24. Lubberts E, Joosten LAB, Helsen MMA, Vandenberg WB (1998) Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone. Cytokine 10(5):361-369
25. Huang SC, Jiang R, Hufnagle WO, Furst DE, Wilske KR, Milner EC (1998) V-H usage and somatic hypermutation in peripheral blood B cells of patients with rheumatoid arthritis (RA). Clin Exp Immunol 112(3):516-527
26. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW (1998) Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 95(16):9465-9470
27. Huizinga TW, Keijsers V, Yanni G, Hall M, Ramage W, Lanchbury J, Pitzalis C, Drossaers-Bakker WK, Westendorp RG, Breedveld FC, Panayi G, Verweij CL (2000) Are differences in interleukin 10 production associated with joint damage? Rheumatology (Oxford) 39(11):1180-1188
28. Rood MJ, Keijsers V, van der Linden MW, Tong TQ, Borggreve SE, Verweij CL, Breedveld FC, Huizinga TW (1999) Neuropsychiatric SLE is associated with imbalance in IL-10 promoter haplotypes. Ann Rheum Dis 58(2):85-89
29. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24(1):1-8
30. Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott P, Hutchinson IV, Ollier WE (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27(2):142-145
31. Coakley G, Mok CC, Hajeer AH, Ollier WE, Turner D, Sinnott PJ, Hutchinson IV, Panayi GS, Lanchbury JS (1998) IL-10 promoter polymorphisms in RA and Felty's syndrome. Br J Rheumatol 37(9):988-991
32. Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG (2003) Genetic polymorphisms in Spanish rheumatoid arthritis patients: An association and linkage study. Genes Immun 4(2):117-121
33. Keijsers V, Verweij CL, Westendorp RGJ, Breedveld FC, Huizinga TW (1997) IL10 polymorphism in relation to production and rheumatoid arthritis [abstract]. Arthritis Rheum 40(Suppl 9):S179
34. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P (1999) Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42(6):1101-1108
35. Eguchi K (2007) Early prediction of joint destruction in rheumatoid arthritis. Clin Calcium 17(4):517-525
36. Johnson PM, Faulk WP (1976) Rheumatoid factor: Its nature, specificity, and production in rheumatoid arthritis. Clin Immunol Immunopathol 6(3):414-430
37. van Zeben D, Breedveld FC (1996) Prognostic factors in rheumatoid arthritis. J Rheumatol Suppl 44:31-33
38. Agrawal S, Misra R, Aggarwal A (2007) Autoantibodies in rheumatoid arthritis: Association with severity of disease in established RA. Clin Rheumatol 26(2):201-204